Sarcomas are traditionally classified in two major genetic groups: the first group includes sarcomas with simple karyotypes and specific genetic alterations like EWS-ATF1 fusions in Ewing sarcomas, KIT mutations in GISTs, or PAX3-FKHR fusions in alveolar rhabdomyosarcomas. This evidence concerns the gene PAX3 and sarcoma.